Soo-Jin Kim

Director Técnico/Científico/I+D en INOZYME PHARMA, INC. .

Fortuna: 2 M $ al 30/04/2024

Health Technology

Consumer Services

Cargos activos de Soo-Jin Kim

Empresas	Cargo	Inicio	Fin
INOZYME PHARMA, INC.	Director Técnico/Científico/I+D	08/03/2022	-

Empresas	Cargo	Inicio	Fin
Boehringer Ingelheim Pharmaceuticals, Inc. Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT.	Corporate Officer/Principal	-	-
HANMI PHARM. CO., LTD.	Corporate Officer/Principal	-	-
BRISTOL-MYERS SQUIBB COMPANY	Corporate Officer/Principal	-	-

Cornell University	Undergraduate Degree
California Institute of Technology	Doctorate Degree

Internacional

Estados Unidos	6
Corea del Sur	2

Operativa

Corporate Officer/Principal	3
Undergraduate Degree	1
Doctorate Degree	1

Sectorial

Health Technology	5
Consumer Services	3

Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Empresas cotizadas	3
BRISTOL-MYERS SQUIBB COMPANY	Health Technology
HANMI PHARM. CO., LTD.	Health Technology
INOZYME PHARMA, INC.	Health Technology

Empresas privadas	1
Boehringer Ingelheim Pharmaceuticals, Inc. Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Pharmaceuticals, Inc. manufactures pharmaceuticals products. It develops and markets drugs for the treatment of respiratory, cancer, cardiovascular, immunological and central nervous system diseases. The company was founded in 1971 and is headquartered in Ridgefield, CT.	Health Technology

Empresas privadas

Health Technology